Clinical Trial Update: Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates neoadjuvant Ivonescimab plus chemotherapy followed by concurrent chemoradiotherapy in high-risk locally advanced cervical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: LOCALLY ADVANCED CERVICAL CANCERS | Phase 2 | Status: NOT_YET_RECRUITING